Cipro (ciprofloxacin HCl)

Company
Bayer

Approval Status
Approved June 1997

Treatment for
acute sinusitis

Possible similar drugs
Cipro; Cipro

Areas
Respiratory

Bayer received approval to market Cipro for acute sinusitis. Cipro’s indications already include the treatment for a wide variety of infectious diseases in adults including lower respiratory infections, urinary tract infections, chronic bacterial prostatis, intra-abdominal infections (with metronidazole), bone and joint infections, and skin and skin structure infections.

Cipro_278 Drug Information

The Cipro_278 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top